Internal Server Error

About RedMedTech Discovery Fund Foundation

RedMedTech Discovery Fund Foundation is a venture capital firm located in Apeldoorn, Netherlands. As of Nov 2018, RedMedTech Discovery Fund Foundation has invested in 19 companies. It primarily invests in Conventional Debt round in Netherlands based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Conventional Debt round of CardiacBooster Overall, RedMedTech Discovery Fund Foundation portfolio has seen 2 acquisitions, namely Quirem Medical and Novioscan.
Key Metrics
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Conventional Debt
Portfolio Acquisitions

RedMedTech Discovery Fund Foundation's List of Top Investments

RedMedTech Discovery Fund Foundation has a portfolio of 19 companies. Their most notable investments include CardiacBooster and Quirem Medical.Their portfolio spans across and Netherlands. They have invested in Life Sciences, High Tech, HealthTech and 5 other sectors, across stages such as Conventional Debt stage. Here is the list of top investments by RedMedTech Discovery Fund Foundation:
CardiacBooster provides percutaneous left ventricular assist devices. The company's devices are used to support the cardiac function of hemodynamically unstable patients. The device focus on ventricular support, cardiogenic shock, and high-risk PCI.

Key facts about CardiacBooster

Quirem Medical, a medical device company, develops microspheres for targeted interventional treatment of liver malignancies. They have developed Holmium based particles, QuiremSpheres, which provides for radioembolisation treatment of liver cancer. Quirem Medical is a spin-off company from UMC Utrecht.

Key facts about Quirem Medical

Developer of hydrophilic bioinspired coatings for medical devices. It makes surface non-fouling and resistant towards surface pollution of micro-organisms. The company provides fast amphiphile solution transfer (FAST) technology that is manufactured from synthetic chemicals but mimics a biological system. It can also be used in drug-screening analysis and industrial application within drug manufacturing, food processing, and water purification.

Key facts about LipoCoat

  • Founded Year: 2016
  • Location: Enschede (Netherlands)
  • Stage: Series A
  • Total Funding till date: $1.64M
  • Employee Count: 16 as on May 31, 2026
  • Investors: Rabobank, EIC Fund and 6 Others
  • Latest Funding Round: Grant (prize money), Oct 01, 2020, $*****
Gatt-tech is a specialty company developing a unique polymer-based General Adhesive Tissue Tape (GATT), to be used as surgical sealant for various surgical applications. Its a technology platform based on polyoxazoline polymers. It uses polyoxazoline, in a modified and activated form, as a building block to construct its GATT sealants.

Key facts about GATT Technologies BV

Amphera is developing dendritic cell immunotherapies for treating malignant mesothelioma and other cancers. The company's lead candidate MesoPher consists of mesothelioma tumor cell, where the cells are instructed with a lysate.

Key facts about Amphera

RedMedTech Discovery Fund Foundation's Investments by Stage

RedMedTech Discovery Fund Foundation has made 2 investments in Conventional Debt stage with an average round size of $486K.

RedMedTech Discovery Fund Foundation's Investments by Sector

RedMedTech Discovery Fund Foundation has a portfolio focused on Life Sciences. Notably, it has invested in 19 Tech companies, 14 Enterprise (B2B) companies, 8 Software companies and at least 7 companies focusing on Tech hardware.

RedMedTech Discovery Fund Foundation's Investments by Geography

RedMedTech Discovery Fund Foundation has made most investments in Netherlands (2).

RedMedTech Discovery Fund Foundation's recent investments

RedMedTech Discovery Fund Foundation has not made any investment in 2026 so far.
Here are the most recent investments by RedMedTech Discovery Fund Foundation:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Nov 26, 2018
Netherlands
Conventional Debt
6831
-
Mar 13, 2014
Netherlands
Conventional Debt
2959
-

Acquired companies in RedMedTech Discovery Fund Foundation's Portfolio

2 companies from RedMedTech Discovery Fund Foundation's portfolio have been acquired. The most recent acquisition was Quirem Medical in Jul 2020 by Terumo Medical for $*****.
Here are RedMedTech Discovery Fund Foundation's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jul 15, 2020
-
-
9894
Apr 01, 2020
-
-
2097

Co-investors of RedMedTech Discovery Fund Foundation

Over the past 12 years, 4 investors have co-invested in RedMedTech Discovery Fund Foundation's portfolio companies. This includes only funds.

FAQs about RedMedTech Discovery Fund Foundation

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford